STAA Earnings & Financial Statements
STAAR Surgical Company
$22.13
-$0.23(-1.03%)
36
Overall
40
Value
27
Tech
42
Quality
Market Cap
$1.12B
Volume
190.61K
52W Range
$15.59 - $35.87
Target Price
$28.22
STAA earnings and financial statements: STAAR Surgical Company's income statement, balance sheet and cash flow statement, annual and quarterly.
STAA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $239.44M | $313.90M | $322.42M | $284.39M | $230.47M |
| Cost of revenue | $57.02M | $74.32M | $69.76M | $61.01M | $51.84M |
| Operating income | -$91.71M | -$12.61M | $28.10M | $43.80M | $33.34M |
| EBITDA | -$78.13M | -$8.07M | $31.83M | $48.88M | $36.98M |
| Net income | -$80.45M | -$20.21M | $21.35M | $39.66M | $27.51M |
| EPS (diluted) | $-1.62 | $-0.41 | $0.43 | $0.78 | $0.50 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $451.68M | $509.52M | $488.69M | $418.82M | $345.78M |
| Total liabilities | $107.49M | $112.19M | $102.74M | $82.71M | $87.22M |
| Shareholders’ equity | $344.18M | $397.33M | $385.95M | $336.11M | $258.56M |
| Cash and equivalents | $153.15M | $144.16M | $183.04M | $86.48M | $199.71M |
| Long-term debt | $32.48M | $34.81M | $31.47M | $27.35M | $28.65M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$34.23M | $15.72M | $14.59M | $35.72M | $43.96M |
| Capital expenditure | -$5.82M | -$23.39M | -$18.19M | -$18.11M | -$13.64M |
| Free cash flow | -$40.05M | -$7.67M | -$3.59M | $17.61M | $30.32M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | STAA | $22.13 | -1.0% | 190.61K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |